Clinical trial
Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
NCT00286182 · Mathew S. Maurer, Other · Completed
Key facts
| NCT number | NCT00286182 |
|---|---|
| Title | Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) |
| Official title | Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status |
| Lead sponsor | Mathew S. Maurer, Other |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Erythropoietin alpha, Placebo |
| Enrollment | 56 |
| Start date | Jul 1, 2007 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Feb 3, 2006 |
| Last update posted | Mar 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: